News
In the heart of 9th century Morocco, a woman quietly rewrote the future of global education. She was Fatima al-Fihri and she ...
Coronary artery disease (CAD) is the leading cause of death in the United States. Although effective preventive treatments ...
Is Rosalind Franklin a ghost that still haunts the history of genomic science? Alan Booth looks into her remarkable story ...
An independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...
Fifteen years later the classic protest tune My Heart Will Go On would be born and go on to poison ... pulled in $5 million ...
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group. The company plans to ...
Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial.
CardiAMP HF II is Evaluating the CardiAMPâ„¢ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...
Universal’s Epic Universe serves up ‘augmented reality’ instead of old-fashioned rollercoasters, but is it worth the $139 ...
Hosted on MSN14d
CU student describes being a double heart transplant recipientJulia Renz spoke about the importance of organ donation. She attends the University of Colorado. Supreme Court’s Alito Calls Block of Deportations ‘Questionable’ Scientists claim to have ...
St. Luke's launched a community health research study called 'DNA Answers,' a free screening that analyzes DNA, determining if you're at a higher risk for certain kinds of cancers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results